Literature DB >> 32313557

Outcomes of scapulothoracic fusion in facioscapulohumeral muscular dystrophy: A systematic review.

Dorsa Kord1, Eva Liu1, Nolan S Horner2, George S Athwal3, Moin Khan2, Bashar Alolabi2.   

Abstract

BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a rare condition associated with selective weakness of the muscles of the upper arm, face, and shoulder girdle, negatively affecting daily activities. Scapulothoracic arthrodesis may restore shoulder function and improve quality of life. The purpose of this review is to evaluate the outcomes and complications of scapulothoracic arthrodesis in FSHD patients.
METHODS: Medline, Pubmed, and Embase were systematically searched. Studies were included if they described scapulothoracic arthrodesis in FSHD with follow-up, and outcomes were adequately reported. Thirteen eligible articles reported the outcomes of 199 arthrodesis in 130 patients.
RESULTS: The mean gain of shoulder forward elevation and abduction were 45° (p < 0.05) and 40° (p < 0.05), respectively. There was an overall cosmetic satisfaction and improved performance of daily activities. There is limited and heterogeneous data on changes in pulmonary function, but such changes are clinically insignificant. The rate of complications was 41% of which 10% were serious, requiring an intervention or re-admission. The most common complications were hardware failure (8%), non-union (6%), and pneumothorax (5%). DISCUSSION: Scapulothoracic arthrodesis improved cosmesis, performance of daily activities and shoulder motion with no clinically significant loss of pulmonary function. The complication rate is high, and some are potentially serious.
© 2019 The British Elbow & Shoulder Society.

Entities:  

Keywords:  facioscapulohumeral muscular dystrophy; outcomes; scapulothoracic arthrodesis

Year:  2019        PMID: 32313557      PMCID: PMC7153204          DOI: 10.1177/1758573219866195

Source DB:  PubMed          Journal:  Shoulder Elbow        ISSN: 1758-5732


  20 in total

1.  Long-term results of scapulothoracic arthrodesis of facioscapulohumeral muscular dystrophy.

Authors:  Yong Girl Rhee; Jeong Han Ha
Journal:  J Shoulder Elbow Surg       Date:  2006 Jul-Aug       Impact factor: 3.019

2.  Thoracoscapular fusion in facioscapulohumeral dystrophy: clinical review of a new surgical method.

Authors:  R S Twyman; G D Harper; M A Edgar
Journal:  J Shoulder Elbow Surg       Date:  1996 May-Jun       Impact factor: 3.019

3.  The shoulder in patients with muscular dystrophy.

Authors:  S A Copeland; O Levy; G C Warner; R M Dodenhoff
Journal:  Clin Orthop Relat Res       Date:  1999-11       Impact factor: 4.176

4.  Scapulothoracic arthrodesis in facioscapulohumeral muscular dystrophy. Review of seventeen procedures with three to twenty-one-year follow-up.

Authors:  W H Bunch; I M Siegel
Journal:  J Bone Joint Surg Am       Date:  1993-03       Impact factor: 5.284

5.  Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT.

Authors:  Nicoline Voet; Gijs Bleijenberg; Jan Hendriks; Imelda de Groot; George Padberg; Baziel van Engelen; Alexander Geurts
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

6.  Medium to long-term outcome of thoracoscapular arthrodesis with screw fixation for facioscapulohumeral muscular dystrophy.

Authors:  Alexander Van Tongel; Ehud Atoun; Ali Narvani; Giuseppe Sforza; Stephen Copeland; Ofer Levy
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

Review 7.  Drug treatment for facioscapulohumeral muscular dystrophy.

Authors:  M R Rose; R Tawil
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Fixation of winged scapula in facioscapulohumeral muscular dystrophy.

Authors:  Sandro Giannini; Cesare Faldini; Stavroula Pagkrati; Gianluca Grandi; Vitantonio Digennaro; Deianira Luciani; Luciano Merlini
Journal:  Clin Med Res       Date:  2007-10

Review 9.  Facioscapulohumeral distrophy and physiotherapy: a literary review.

Authors:  Bruno Corrado; Gianluca Ciardi
Journal:  J Phys Ther Sci       Date:  2015-07-22

Review 10.  Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature.

Authors:  Adam Philip Denny; Alison Kay Heather
Journal:  Oxid Med Cell Longev       Date:  2017-06-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.